Zoë A. Hughes - Concepedia

Author

Zoë A. Hughes

Also Known As

Archer, A., J Heitmann, Justin Piro, Z A Hughes, Z. A. Hughes, Z. Hughes, Z.A Hughes, Z.A. Hughes, ZA Hughes, Zoë A. Hughes

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)GlaxoSmithKline (United Kingdom)Princeton University University College London King's College London

About

Zoë A. Hughes is an author at Pfizer (United States) specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	32	2.3K
2	Social Sciences	19	22	1.6K
3	Behavioral Sciences	3	3	341
4	Health Sciences	2	2	82
5	Anesthesia	1	1	26

Zoë A. Hughes

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Histidine Decarboxylase Deficiency Causes Tourette Syndrome: Parallel Findings in Humans and Mice Lissandra Castellan Baldan, Kyle A. Williams, Jean‐Dominique Gallezot, Neuron Parallel FindingsPsychiatrySyndromic AutismNeuropharmacologyNeuroscience	2014	251
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes Stacey J. Sukoff Rizzo, Sarah J. Neal Webb, Zoë A. Hughes, Translational Psychiatry	2012	232
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice Renzo Mancuso, Gemma Fryatt, Madeleine Cleal, Brain ImmunologyCell DeathNeurochemical BiomarkersNeuroinflammationInflammation	2019	224
Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test Rachel L. Navarra, Radka Graf, Youping Huang, Progress in Neuro-Psychopharmacology and Biological Psychiatry Behavioral SciencesPsychoactive DrugBehavioral NeuroscienceAddictionImpulsivity	2007	181
BACE1 (β-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes Steve Harrison, Alex Harper, Julie A. Hawkins, Molecular and Cellular Neuroscience Behavioral ChangesMolecular NeuroscienceBehavioral NeuroscienceNeurotransmitterNeurochemical Deficits	2003	149
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist Robert H. Ring, Lee E. Schechter, Sarah K. Leonard, Neuropharmacology Molecular PharmacologyBehavioral NeuroscienceMedicineFunctional SelectivityBehavioral Pharmacology	2009	145
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease Stephen Harrison, Charlie Reavill, Gerald L. Brown, Molecular and Cellular Neuroscience Lpa1 Receptor-deficient MicePsychiatric DiseasePsychiatryPsychiatric DisordersMedicine	2003	125
The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal Cortex Stephanie M. McTighe, Sarah J. Neal Webb, Qian Lin, PLoS ONE NeuropsychologyBrain FunctionDevelopmental Cognitive NeurosciencePrefrontal CortexBtbr Mice	2013	124
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone Zoë A. Hughes, Kathryn R. Starr, Christopher J. Langmead, European Journal of Pharmacology PsychiatryFunctional SelectivityMedicinePsychopharmacologyNeurochemical Evaluation	2005	121
The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise? Stacey J. Sukoff Rizzo, Sarah K. Leonard, A. Gilbert, Journal of Pharmacology and Experimental Therapeutics	2011	103

Page 1